Martha MacLean

A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies

Sebastién J. Hotte, Hal W. Hirte, Eric X. Chen et al. · Clinical Cancer Research · 2008 · 189 citations

Life Sciences, Oncology, Pharmacology +17

Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors

Lillian L. Siu, Ignacio Durán, Wells A. Messersmith et al. · Journal of Clinical Oncology · 2008 · 118 citations

Medicine, Oncology, Pharmacology +16

Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors

Ignacio Durán, Sebastién J. Hotte, Holger W. Hirte et al. · Clinical Cancer Research · 2007 · 97 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks

Alison Davis, Karen A. Gelmon, Lillian L. Siu et al. · Investigational New Drugs · 2003 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +11

Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital

Jeremy Ho, Gregory R. Pond, Colin Newman et al. · BMC Cancer · 2006 · 65 citations · Full text

Medicine, Oncology, Cancer Control +16